Skip to content

Randomised trial, 2005

For PMDD, is it better to take escitalopram throughout the luteal phase or starting when symptoms appear?

Both approaches significantly improved PMDD symptoms by about 50-57%. Luteal phase dosing may work better for women with severe symptoms.

Moderate study design 27 women with PMDD

What they did

27 women with PMDD were randomly assigned to take escitalopram 10-20 mg per day either during the entire luteal phase (13 women) or starting when symptoms appeared (14 women). Treatment lasted 3 menstrual cycles and symptoms were tracked using several rating scales.

What they found

Both approaches significantly improved symptoms overall (p=.003). The luteal phase dosing group had a 57% decrease in symptoms and 11 of 13 women improved by more than 50%. The symptom-onset group had a 51% decrease and 9 of 14 women improved by more than 50%. Among women who started medication when symptoms appeared, those with more severe PMDD were less likely to respond.

What it means for you

Both dosing schedules work for PMDD, but starting medication before symptoms appear may be more reliable, especially for severe PMDD. This is a small preliminary study.

27

women randomized

57%

symptom decrease with luteal phase dosing

51%

symptom decrease with symptom-onset dosing

About the study

Original title
A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder
Authors
Freeman EW, Sondheimer SJ, Sammel MD et al.
Journal
The Journal of clinical psychiatry
Year
2005
Study design
Randomised trial
Participants
14
What was tested
Escitalopram 10-20 mg per day, luteal phase throughout or starting when symptoms appeared, 3 cycles

Topics